Pharmaceutical Intermediates Market is likely to register CAGR of 4.3% through 2030

The rapidly increasing prevalence of chronic diseases around the world is likely to fuel the demand for novel medications and better treatment options, propelling the worldwide market forward. Because of the increased desire for novel treatment options, there has been an increase in the use of drug intermediates as well as their use in research and clinical investigations.

Leading biotechnology and pharmaceutical companies, as well as research institutes, are increasingly focusing on R&D operations related to medication creation and development. The global Pharmaceutical Intermediates Market size was valued at roughly US$ 30 billion in 2020 and is expected to grow at a CAGR of 4.3% from 2020 to 2030.

Pharmaceutical Intermediates are utilised as raw materials in the production of bulk medicines. These are the byproducts of the production of an active pharmaceutical ingredient (API). Pharmaceutical and biotech businesses, on the other hand, can use these drug intermediates for research and development (R&D). Furthermore, Pharmaceutical Intermediates are classified into three types: high quality Pharmaceutical Intermediates, moderate quality Pharmaceutical Intermediates, and premium grade intermediates. The high-quality and premium Pharmaceutical Intermediates are mostly employed in research and development.

For Details on Vendors and Their Offerings – Request A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4515

COVID-19 pandemic is negatively impacting Pharmaceutical Intermediates sales due to supply chain disruptions caused due to extended period of lockdown. Nonetheless growth is expected to recover because an increasing number of pharma companies are engaging in research and development to find effective treatment and vaccination for COVID-19 virus.

Key Takeaways from Pharmaceutical Intermediates Marker Study

• Throughout the predicted period, demand for chiral intermediates will rise.
• The worldwide Pharmaceutical Intermediates market will be dominated by East Asia. China is likely to emerge as the region’s most profitable market for Pharmaceutical Intermediates.
• Analgesics will remain the dominant application, growing at a Y-o-Y rate of more than 6% through 2020.
• Generic drug intermediates are predicted to be in higher demand than branded drug intermediates.
• Pharmaceutical Intermediates will continue to be in high demand from biotech and pharmaceutical companies.

“Rising drug development activities worldwide as well as increasing adaption of Pharmaceutical Intermediates as raw material are driving the growth of global Pharmaceutical Intermediates market” says the FMI Analyst

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you@ https://www.futuremarketinsights.com/ask-question/rep-gb-4515

Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players

Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

• On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business.
• On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021.

Key Participant Insights

The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates.

The key market players covered by FMI include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co., Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd consolidating their positions through mergers, acquisitions and new product launches.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/4515

Pharmaceutical Intermediates Market – Key Segments

Product

• Chemical Intermediates
• Bulk Drug Intermediates
  • Chiral Intermediates
  • Achiral Intermediates
• Custom Intermediates

Category

• Branded Drug Intermediates
• Generic Drug Intermediates

Application

• Analgesics
• Anti-inflammatory Drug
• Cardiovascular Drugs
• Anti-diabetic Drugs
• Antimicrobial Drugs
• Anti-cancer Drugs
• Others

End User

• Biotech and Pharma Companies
• Research Laboratory
• CMOs/CROs

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs